Survivin improves the early recognition of rheumatoid arthritis among patients with arthralgia: A population-based study within two university cities of Sweden
Seminars in Arthritis and Rheumatism Nov 14, 2017
Erlandsson MC, et al. - The utility of survivin for preclinical recognition of rheumatoid arthritis (RA) among patients with unexplained arthralgia was tested. In addition to improving RA risk estimation, measurement of survivin in serum prospectively predicted RA development in this patient population. In addition, survivin may indicate a phase preceding autoantibody production.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
